%0 Journal Article %T Inhibition of MEK, a canonical KRAS pathway effector in KRAS mutant NSCLC %A Rosell, Rafael %A Karachaliou, Niki %A Codony-Servat, Carles %A Ito, Masaoki %J Translational Lung Cancer Research %D 2018 %B 2018 %9 %! Inhibition of MEK, a canonical KRAS pathway effector in KRAS mutant NSCLC %K %X KRAS mutant NSCLC cells require active nuclear export of Iκβα (also known as NFKBIA), a negative regulatory protein of NF-κB signaling, for maintaining survival signaling (1-3). Nuclear export receptor XPO1 correlates with KRAS mutation status. %U https://tlcr.amegroups.org/article/view/20503 %P S183-S186 %@ 2226-4477